New Delhi: W Health Ventures, a healthcare-focused venture capital firm, has launched its second fund with a target size of $70 million (Rs 609 crore) to support healthcare startups in India and the US.
With Fund II, W Health plans to go beyond traditional investing by co-creating companies and offering hands-on operational support.
Focus areas
The new fund will place special emphasis on underserved and high-impact areas such as oncology, psychiatry, geriatric care, longevity, and preventive health. These segments are seen as having significant unmet patient needs and limited innovation in the Indian healthcare landscape.
Previous investments
Fund II has already deployed capital into two ventures. The first is Everhope Oncology, a cancer care platform incubated in partnership with Narayana Health. The platform aims to standardize and scale access to high-quality oncology services across India, covering chemotherapy, surgical oncology, diagnostics, and supportive care. W Health and Narayana Health have jointly invested about $10 million in the venture.
The second investment is in a stealth-mode startup focused on psychiatry. Structured as a cross-border platform, it offers managed services to psychiatry clinics in the US, supporting practice management, outcome tracking, and revenue optimization.
With Fund II, the firm plans to expand its operational team by adding four senior partners. These new hires will bring expertise in offline care delivery, AI-driven services, and US go-to-market strategy, reinforcing W Health’s company-building approach.
Also Read
Playbook Partners to Invest $240 Million in Indian Startups Over Two Years
